Nov 30, 2021 09:49 PM (GMT+8) · EqualOcean
Financial Associated Press, Nov. 30 - Nanjing Pharmaceutical announced that Fujian Tongchun, the holding subsidiary of the company, plans to invest in the construction of Fujian Tongchun biomedical industrial park (phase I), with a total investment of about 471.6 million yuan.